Cover Image
市場調查報告書

置入式輸液幫浦:開發中產品分析

Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 358889
出版日期 內容資訊 英文 41 Pages
訂單完成後即時交付
價格
Back to Top
置入式輸液幫浦:開發中產品分析 Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年06月01日 內容資訊: 英文 41 Pages
簡介

本報告提供目前開發中的置入式 (樹叢型) 輸液幫浦之開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等系統性資訊。

第1章 目錄

第2章 簡介

  • 置入式輸液幫浦概要

第3章 開發中的產品

  • 置入式輸液幫浦 - 開發中產品:各開發階段
  • 置入式輸液幫浦 - 開發中產品:各地區
  • 置入式輸液幫浦 - 開發中產品:各法規途徑
  • 置入式輸液幫浦 - 開發中產品:各核准時期 (預定)

第4章 置入式輸液幫浦:開發中的開發中產品 (各企業)

  • 置入式輸液幫浦企業 - 開發中產品:各開發階段
  • 置入式輸液幫浦 - 開發中產品:各開發階段

第5章 置入式輸液幫浦企業與產品概要

  • Alnylam Pharmaceuticals, Inc.
  • Debiotech S.A.
  • Delpor, Inc.
  • Eksigent Technologies, LLC
  • Eli Lilly and Company
  • Flowonix Medical, Inc.
  • FluidSynchrony, LLC
  • Intarcia Therapeutics, Inc.
  • Medallion Therapeutics, Inc.
  • Nano Precision Medical
  • Pharmaco-Kinesis Corporation
  • University of Minnesota
  • University of Southern California

第6章 置入式輸液幫浦:最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0195EPD

GlobalData's Medical Devices sector report, "Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2016" provides an overview of Implantable Infusion Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Infusion Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Implantable Infusion Pumps under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Implantable Infusion Pumps and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Implantable Infusion Pumps under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Implantable Infusion Pumps Overview

3. Products under Development

  • 3.1. Implantable Infusion Pumps - Pipeline Products by Stage of Development
  • 3.2. Implantable Infusion Pumps - Pipeline Products by Territory
  • 3.3. Implantable Infusion Pumps - Pipeline Products by Regulatory Path
  • 3.4. Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date

4. Implantable Infusion Pumps - Pipeline Products under Development by Companies

  • 4.1. Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development
  • 4.2. Implantable Infusion Pumps - Pipeline Products by Stage of Development

5. Implantable Infusion Pumps Companies and Product Overview

  • 5.1. Alnylam Pharmaceuticals, Inc. Company Overview
    • 5.1.1. Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Debiotech S.A. Company Overview
    • 5.2.1. Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Delpor, Inc. Company Overview
    • 5.3.1. Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Eksigent Technologies, LLC Company Overview
    • 5.4.1. Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Eli Lilly and Company Company Overview
    • 5.5.1. Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Flowonix Medical, Inc. Company Overview
    • 5.6.1. Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. FluidSynchrony, LLC Company Overview
    • 5.7.1. FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Intarcia Therapeutics, Inc. Company Overview
    • 5.8.1. Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Medallion Therapeutics, Inc. Company Overview
    • 5.9.1. Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Nano Precision Medical Company Overview
    • 5.10.1. Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Pharmaco-Kinesis Corporation Company Overview
    • 5.11.1. Pharmaco-Kinesis Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. University of Minnesota Company Overview
    • 5.12.1. University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. University of Southern California Company Overview
    • 5.13.1. University of Southern California Pipeline Products & Ongoing Clinical Trials Overview

6. Implantable Infusion Pumps- Recent Developments

  • 6.1. May 18, 2016: Flowonix Medical Appoints Larry Heaton as CEO
  • 6.2. May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026
  • 6.3. May 06, 2016: Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes
  • 6.4. Nov 02, 2015: Flowonix Medical and Connecticut Pain Care Announce the First Implant of the Prometra II Pump in Danbury, CT

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development
  • Table 2: Implantable Infusion Pumps - Pipeline Products by Territory
  • Table 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path
  • Table 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
  • Table 5: Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development
  • Table 6: Implantable Infusion Pumps - Pipeline Products by Stage of Development
  • Table 7: Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: ALN-HTT Infusion System - Product Status
  • Table 9: ALN-HTT Infusion System - Product Description
  • Table 10: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: MIP Device - Product Status
  • Table 12: MIP Device - Product Description
  • Table 13: Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Delpor Microfabricated Nanopore Device - Product Status
  • Table 15: Delpor Microfabricated Nanopore Device - Product Description
  • Table 16: Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Implantable Drug Delivery System - Product Status
  • Table 18: Implantable Drug Delivery System - Product Description
  • Table 19: Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Drug Delivery System - Parkinson's Disease - Product Status
  • Table 21: Drug Delivery System - Parkinson's Disease - Product Description
  • Table 22: Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Implanted Drug Delivery System - Product Status
  • Table 24: Implanted Drug Delivery System - Product Description
  • Table 25: FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: FluidSync Pump - Product Status
  • Table 27: FluidSync Pump - Product Description
  • Table 28: Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: ITCA 638 - Product Status
  • Table 30: ITCA 638 - Product Description
  • Table 31: ITCA 650 Osmotic Pump - Product Status
  • Table 32: ITCA 650 Osmotic Pump - Product Description
  • Table 33: ITCA 880 - Product Status
  • Table 34: ITCA 880 - Product Description
  • Table 35: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Medallion Infusion System - Product Status
  • Table 37: Medallion Infusion System - Product Description
  • Table 38: Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Nano Portal Capsule - Product Status
  • Table 40: Nano Portal Capsule - Product Description
  • Table 41: Pharmaco-Kinesis Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Second Generation Metronomic Biofeedback Pump - Product Status
  • Table 43: Second Generation Metronomic Biofeedback Pump - Product Description
  • Table 44: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Infusion Micropump - Product Status
  • Table 46: Infusion Micropump - Product Description
  • Table 47: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Drug Infusion Pump - Product Status
  • Table 49: Drug Infusion Pump - Product Description
  • Table 50: Glossary

List of Figures

  • Figure 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development
  • Figure 2: Implantable Infusion Pumps - Pipeline Products by Territory
  • Figure 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path
  • Figure 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date
Back to Top